Stocks · News reference

Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

Aug 10, 2026, 11:58 AMBenzinga Newsdesk

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 7, 2026, 1:29 PMBenzinga Newsdesk
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106
Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.
Read original at benzinga
ZBH
BenzingaAug 6, 2026, 6:04 PMBenzinga Newsdesk
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110
RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.
Read original at benzinga
ZBH
BenzingaAug 6, 2026, 4:47 PMBenzinga Newsdesk
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93
Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.
Read original at benzinga
ZBH